Laminin Alpha 2 in Development

Agency: National Institute of Health (NIH)
Institute: Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type: Research Project (R01)
Project #: 1R01HD031636-01A2
Application #: 2204300
Study Section: Pathobiochemistry Study Section (PBC)


NIH 2004 R01 HD	Laminin Alpha 2 in Tissue Regeneration Engvall, Eva S. / Sanford-Burnham Medical Research Institute	$384,327
NIH 2003 R01 HD	Laminin Alpha 2 in Tissue Regeneration Engvall, Eva S. / Sanford-Burnham Medical Research Institute	$373,134
NIH 2002 R01 HD	Laminin Alpha 2 in Tissue Regeneration Engvall, Eva S. / Sanford-Burnham Medical Research Institute	$362,267
NIH 2001 R01 HD	Laminin Alpha 2 in Tissue Regeneration Engvall, Eva S. / Sanford-Burnham Medical Research Institute	$351,714
NIH 2000 R01 HD	Laminin Alpha 2 in Tissue Regeneration Engvall, Eva S. / Sanford-Burnham Medical Research Institute	$341,470
NIH 1999 R01 HD	Laminin Alpha 2 in Development Engvall, Eva S. / Sanford-Burnham Medical Research Institute
NIH 1998 R01 HD	Laminin Alpha 2 in Development Engvall, Eva S. / Sanford-Burnham Medical Research Institute
NIH 1997 R01 HD	Laminin Alpha 2 in Development Engvall, Eva S. / Sanford-Burnham Medical Research Institute
NIH 1996 R01 HD	Laminin Alpha 2 in Development Engvall, Eva S. / Sanford-Burnham Medical Research Institute

Homma, Sachiko; Iwasaki, Masahiro; Shelton, G Diane et al. (2006) BAG3 deficiency results in fulminant myopathy and early lethality. Am J Pathol 169:761-73

Ruoslahti, E; Engvall, E (1997) Integrins and vascular extracellular matrix assembly. J Clin Invest 99:1149-52

Ruoslahti, E; Engvall, E (1997) Integrins and vascular extracellular matrix assembly. J Clin Invest 100:S53-6